A year ago, Tadeusz Hawrot wrote about the beginnings of a promising development in drug policy; the potential rescheduling of psychedelics in Ukraine.

On June 11th, 2025, Texas passed Senate Bill 2308, allocating $50 million in state funds towards the research and development of ibogaine for medical use. The bill had support from a large bipartisan majority and was signed by Gov. Greg Abbott, authorising universities, hospitals, and drug developers to work towards potential FDS-approved ibogaine treatments for veterans.